133 related articles for article (PubMed ID: 8883967)
1. Prognostic significance of serum c-erbB-2 protein in breast cancer patients.
Willsher PC; Beaver J; Pinder S; Bell JA; Ellis IO; Blamey RW; Robertson JF
Breast Cancer Res Treat; 1996; 40(3):251-5. PubMed ID: 8883967
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapy.
Classen S; Kopp R; Possinger K; Weidenhagen R; Eiermann W; Wilmanns W
Tumour Biol; 2002; 23(2):70-5. PubMed ID: 12065844
[TBL] [Abstract][Full Text] [Related]
3. c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value.
Molina R; Jo J; Filella X; Zanon G; Pahisa J; Mu noz M; Farrus B; Latre ML; Escriche C; Estape J; Ballesta AM
Breast Cancer Res Treat; 1998 Sep; 51(2):109-19. PubMed ID: 9879773
[TBL] [Abstract][Full Text] [Related]
4. Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.
Mehta RR; McDermott JH; Hieken TJ; Marler KC; Patel MK; Wild LD; Das Gupta TK
J Clin Oncol; 1998 Jul; 16(7):2409-16. PubMed ID: 9667258
[TBL] [Abstract][Full Text] [Related]
5. Serum c-erbB-2 protein in breast cancer patients.
Chearskul S; Sinlarat P; Bhothisuwan K; Churintrapun M; Ornrhebroi S; Klinsala N; Sungkabunchoo S
J Med Assoc Thai; 2000 Aug; 83(8):886-93. PubMed ID: 10998842
[TBL] [Abstract][Full Text] [Related]
6. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
Meenakshi A; Kumar RS; Kumar NS
J Immunoassay Immunochem; 2002; 23(3):293-305. PubMed ID: 12227416
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum and urinary c-erbB-2 levels in colorectal cancer.
Tsigris C; Karayiannakis AJ; Zbar A; Syrigos KN; Baibas N; Diamantis T; Alexiou D
Cancer Lett; 2002 Oct; 184(2):215-22. PubMed ID: 12127694
[TBL] [Abstract][Full Text] [Related]
8. Serum c-erbB-2 protein is a useful marker for monitoring tumor recurrence of the breast.
Imoto S; Wada N; Hasebe T; Ochiai A; Kitoh T
Int J Cancer; 2007 Jan; 120(2):357-61. PubMed ID: 17044019
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of c-erbB-2 serum protein in metastatic breast cancer.
Fehm T; Maimonis P; Katalinic A; Jäger WH
Oncology; 1998; 55(1):33-8. PubMed ID: 9428373
[TBL] [Abstract][Full Text] [Related]
10. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients.
Leitzel K; Teramoto Y; Sampson E; Mauceri J; Langton BC; Demers L; Podczaski E; Harvey H; Shambaugh S; Volas G
J Clin Oncol; 1992 Sep; 10(9):1436-43. PubMed ID: 1355522
[TBL] [Abstract][Full Text] [Related]
11. Serum c-erB-2 levels in monitoring of operable breast cancer patients.
Imoto S; Kitoh T; Hasebe T
Jpn J Clin Oncol; 1999 Jul; 29(7):336-9. PubMed ID: 10470658
[TBL] [Abstract][Full Text] [Related]
12. Detection of urokinase plasminogen activator receptor and c-erbB-2 in sera of patients with breast and ovarian carcinoma.
Mabrouk RA; Ali-Labib R
Clin Biochem; 2003 Oct; 36(7):537-43. PubMed ID: 14563447
[TBL] [Abstract][Full Text] [Related]
13. MUC1 serum assays in breast cancer: tumor specificities and reference levels.
Bjerner J; Norum LF; Nilsson O; Nustad K
Tumour Biol; 2002; 23(6):315-23. PubMed ID: 12677089
[TBL] [Abstract][Full Text] [Related]
14. Serum HER2/ECD value in stage I and II early breast cancer: need of a lower cut-off?
Badzek S; Kelovic VL; Plestina S; Humar I; Veir Z; Mihaljevic Z
Wien Klin Wochenschr; 2011 Dec; 123(23-24):726-31. PubMed ID: 22113445
[TBL] [Abstract][Full Text] [Related]
15. C-erbB-2 protein in the sera of breast cancer patients.
Narita T; Funahashi H; Satoh Y; Takagi H
Breast Cancer Res Treat; 1992; 24(2):97-102. PubMed ID: 8095169
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
[TBL] [Abstract][Full Text] [Related]
17. Measurement of c-erbB-2 proteins in sera from patients with carcinomas and in breast tumor tissue cytosols: correlation with serum tumor markers and membrane-bound oncoprotein.
Wu JT; Astill ME; Gagon SD; Bryson L
J Clin Lab Anal; 1995; 9(3):151-65. PubMed ID: 7541455
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of C-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases.
Molina R; Jo J; Filella X; Bruix J; Castells A; Hague M; Ballesta AM
Tumour Biol; 1997; 18(3):188-96. PubMed ID: 9143415
[TBL] [Abstract][Full Text] [Related]
19. The potential use of saliva to detect recurrence of disease in women with breast carcinoma.
Bigler LR; Streckfus CF; Copeland L; Burns R; Dai X; Kuhn M; Martin P; Bigler SA
J Oral Pathol Med; 2002 Aug; 31(7):421-31. PubMed ID: 12165061
[TBL] [Abstract][Full Text] [Related]
20. Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour.
Andersen TI; Paus E; Nesland JM; McKenzie SJ; Børresen AL
Acta Oncol; 1995; 34(4):499-504. PubMed ID: 7605658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
